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국 문 요 약
HEI-OC1 세포에서의 Cisplatin 이독성에 대한 alpha-
tocopherol의 효과
목적: Alpha-tocopherol은 methylated phenol계열로 지용성 항산화물질로서 알려져 있으며
유리기를 줄이고 항산화 역할을 하는 비타민 E의 다른 형태이다. 저자는 alpha-
tocopherol의 항상화 효과가 cisplatin에 의한 세포독성을 보호할 수 있음을 토대로 HEI-
OC1 청각세포에서 cisplatin유발 이독성에 대한 효과를 알아보았다. 실험 재료 및 방법:
10 μM 농도의 alpha-tocopherol을 24시간동안 HEI-OC1세포에 전처치 한 후, 15 μM 
농도의 cisplatin을 추가하였다. 48시간 후 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT)를 이용하여 세포 생존율을 측정하였으며 2′,7′-
dichlorofluorescein diacetate (DCFH-DA) 형광 염료를 이용하여 세포내 활성산소 농도를
측정하였다. 이후 Annexin V-FITC and propidium iodide (PI) 염색으로 세포자멸사의
패턴을 분석하였고 caspase3/CPP32 형광분석 키트를 이용하여 caspase-3 활성도를
측정하였다. 또한 면역 블로팅을 통해 poly-ADP-ribose polymerase(PARP)를 분석하였다. 
결과: HEI-OC1 세포에 10 μM의 alpha-tocopherol을 전처치한 결과 cisplatin 유발
이독성에 대한 보호효과가 있음을 확인하였고 이독성으로 인하여 상승된 활성산소의
양도 유의하게 감소함을 알 수 있었다. Alpha-tocopherol을 전처치한 군은 cisplatin 
단독군에 비해 활성산소를 15% 감소시켰고, 세포 괴사 및 후기 세포자멸사의 비율이
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50% 감소하였다. 또한 alpha-tocopherol은 caspase-3 활성도 및 PARP 양을 감소시켰다.
결론: 본 연구는 HEI-OC1 청각 세포에서 cisplatin 유발 이독성에 대한 alpha-
tocopherol의 보호효과에 대한 것으로, alpha-tocopherol은 cisplatin유발 이독성으로
인하여 증가된 활성산소를 유의하게 감소시키며 세포자멸사를 줄이는 역할을 하는
것으로 판단된다.
핵심되는 말: Alpha-tocopherol; Cisplatin; 활성산소; 이독성; 항산화
１1. Introduction
Cisplatin (cis-diamminedichloroplatinum II; CDDP) is a well-known chemotherapeutic agent that 
is widely used in the treatment of human solid tumors in head and neck, ovarian, cervical, and 
bladder cancers, among others. In spite of its efficacy, cisplatin has several severe adverse effects 
such as nephrotoxicity, neurotoxicity, and ototoxicity [1, 2]. Among them, ototoxicity, a medication-
induced auditory or vestibular functional loss, can be progressive and permanent. Cisplatin has been 
reported to cause the death of outer hair cells in the organ of Corti [3, 4], and it is believed that 
cisplatin induces this ototoxicity by generating reactive oxygen species (ROS), resulting in the 
depletion of glutathione and antioxidant enzymes [5-7].
Tocopherols are a class of methylated phenols, known as fat-soluble antioxidants. Alpha-
tocopherol is a form of vitamin E, which reduces free radicals and acts as an antioxidant. It has 
several different forms, all of which have a chromanol ring with a hydroxyl chain that donates a 
hydrogen atom to reduce ROS. Tocopherol is abundant in natural olive and sunflower oils and has 
been considered to be an effective antioxidant or protective drug without side effects when used 
clinically [8]. 
The effects of α-tocopherol on cisplatin-induced ototoxicity were examined in guinea pigs, where 
it suppressed ototoxicity and nephrotoxicity by suppressing increased ROS production [9]. Alpha-
tocopherol and tiopronin co-therapy was demonstrated to significantly slow the progressive high-
frequency hearing loss induced by cisplatin [10]. Alpha-tocopherol also protects against cisplatin-
induced ototoxicity without interfering with cisplatin’s antitumor efficacy [11].
Our study investigated the antioxidative effect of α-tocopherol on cisplatin-induced 
ototoxicity in HEI-OC1 auditory cells.
２2. Material and methods
2.1. Chemicals
Cisplatin (CAS no. 15663-27-1) and α-tocopherol (CAS no. 4345-03-3) were purchased from 
Sigma Chemical Co. (St Louis, MO, USA).
2.2. Cell culture
The HEI-OC1 cell line was kindly provided by F. Kalinec (House Ear Institute, Los Angeles, CA, 
USA). HEI-OC1 cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco 
BRL, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; genDEPOT, Texas, U.S.A) 
and 50 U/ml interferon-γ without antibiotics at 33°C under an atmosphere of 10% CO2. HEI-OC1 
cells express several molecular markers that are characteristic of sensory cells in the organ of Corti, 
and are extremely sensitive to ototoxic drugs [12]. Cisplatin was prepared as a 5 mM stock solution 
in the cell culture media and added directly to the culture well.
2.3. Cell viability assay 
Cell viability was measured by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT, Sigma) assay. The auditory cells (2 × 104 cells/well of a 48-well plate) were 
incubated with 15 μM of cisplatin (IC50; the concentration required for 50% inhibition) for 48 h. In 
order to examine the protective effect of α-tocopherol on cisplatin-induced cytotoxicity in HEI-OC1 
３cells, the cells were pretreated with α-tocopherol at a concentration of 10 μM for 24 h, before 
exposure to cisplatin (15 μM, 48 h). For the MTT assay, 100 μL of the MTT solution (5 mg/mL) 
was added to the cells, and then the plates were incubated for 3 h at 33°C in an atmosphere of 10% 
CO2 and 90% air. The MTT cell assay is designed to measure cell viability and proliferation in the 
presence of a combination of cytotoxic or protective agents and is based on the quantitative 
measurement of the extracellular reduction of the yellow-colored, water-soluble Tetrazolium dye to 
insoluble formazan crystals by metabolically active cells. This reduction is mediated by the 
mitochondrial enzyme lactate dehydrogenase (LDH). LDH is found in most body tissues, including 
blood cells and cardiac myocytes. Since LDH is released at the time of tissue damage, it is used as 
a marker of common cellular damage and apoptotic/necrotic disease. When dissolved in an 
appropriate solvent, these formazan crystals exhibit a purple color, the intensity of which is 
proportional to the number of viable cells and can be measured by using a spectrophotometer at 570
nm. The optical density was measured by using a microplate reader at 570 nm (Spectra Max, 
Molecular Devices, Sunnyvale, CA, USA).
2.4. Measurement of intracellular ROS production
The intracellular ROS level was measured by using a fluorescent dye, 2′,7′-dichlorofluorescein 
diacetate (DCFH-DA, Calbiochem, USA). In the presence of an oxidant, DCFH is converted to the 
highly fluorescent 2′, 7′-dichlorofluorescein (DCF). For the assay, HEI-OC1 cells were incubated in 
the dark for 30 min at 37°C with 50 μM DCFH-DA. Fluorescence was analyzed by using a FACScan 
flow cytometer (BD Biosciences, Heidelberg, Germany) at an excitation wavelength of 495 nm and 
an emission wavelength of 530 nm (FL-1) with gating at 10,000 cells/sample. 
４2.5. Fluorescent microscope
Cells were grown on the Cell Culture Slides (SPL, Gyeonggido, Korea). Cells were washed twice 
with serum-free medium without phenol red and incubated with 50 mM DCFH-DA in serum-free 
medium without phenol red for 30 min at 33℃. After three washings with serum free medium 
without phenol red, cells were fixed with 3.7% glutaraldehyde for 10 min at room temperature. Cells 
were incubated with 10 mg/mL Hoechst 33258 (Sigma, St Louis, MO, USA) for 20 min at room 
temperature in the dark. After washing twice with PBS and mounting, the fluorescence images from 
multiple fields of view were obtained using an Olympus ix71 microscopy with a long-term real-time 
live cell image system (LAMBDA DG-4, Sutter Int., Novato, CA, USA).
2.6. Flow cytometric assay of apoptosis
The rate of apoptosis among HEI-OC1 auditory cells was determined by using Annexin V-FITC 
(Ezway Annexin V-FITC Apoptosis Detection Kit, Komabiotech, Seoul, Korea). The specific 
binding of Annexin V-FITC occurred during incubation of the cells for 15 min at room temperature 
in binding buffer containing a saturating concentration of Annexin V-FITC and PI (propidium 
iodide). Afterwards, the cells were analyzed by flow cytometry (BD Biosciences, Heidelberg, 
Germany) for a cell count of 10000. 
2.7. Measurement of caspase-3 activity
５The enzymatic activity of caspase-3 was assayed with a caspase3/CPP32 fluorometric assay kit 
(Biovision, Milpitas, California, USA) according to the manufacturer's protocol. Auditory cell line 
lysate was prepared in a lysis buffer on ice for 10 min and centrifuged for 5 min at 14,000 rpm. The 
protein concentration in each lysate was measured. The catalytic activity of caspase-3 in the cell 
lysate was measured by proteolytic cleavage of 50 mM DEVD-pNA and fluorometric substrate for 
2 h at 37°C. The mixture incubated with no DEVD-pNA substrate was used as a negative control. 
The plates were read by microplate reader (Spectra Max, Molecular Devices, Sunnyvale, CA, USA) 
at a 400 nm excitation filter and a 505 nm emission filter.
2.8. Immunoblotting of PARP
Following primary antibodies were purchased from Cell Signaling Technology (Danvers, MA, 
USA): poly-ADP-ribose polymerase(PARP). For the assay, HEI-OC1 cells were cultured and 
treated with 15 uM cisplatin for 48 h in the presence or absence of alpha tocopherol (10uM, 24 h 
pretreatment). Cell lysates were used in RIPA buffer (Cell Signaling Technology, Danvers, MA, 
USA). The proteins (20 ug/sample) were immediately heated for 5 min at 100℃ and were subjected 
to SDS-PAGE on gels. Separated proteins were transferred to nitrocellulose membranes, and 
western blotting was performed using a gel loading kit and protein transfer system kit (BioRad, 
Hercules, CA, USA). Membranes were blocked by treatment with 5% skim milk in Tris buffer 
solution containing 0.1% Tween (TBST) and subsequently incubated with the primary polyclonal 
antibodies at a final dilution of 1: 1000. After three washes in TBST, membranes were incubated 
with peroxidase conjugated secondary antibodies (final dilution, 1: 2000) in blocking buffer for 1 h 
and subsequently washed. Detection was performed by chemiluminescence using an ECL solution 
６(Gendepot, Barker TX, USA). Beta-actin was used as a loading control. For the calculation of band 
density, Image J was used (Imagej.nih.gov/ij/index.html).
2.9. Statistical analysis
All values are represented as mean ± standard deviation (S.D.). For data analysis, we used the 
SPSS 22.0 statistical program. The paired t test was used for pairs of data, while multiple data were 
analyzed by ANOVA. A p value of less than 0.05 was considered statistically significant.
3. Results
3.1. Tocopherol protects against cisplatin-induced cytotoxicity in auditory cells
To establish an appropriate dose of cisplatin, cell viability was examined in the HEI-OC1 cell line. 
As shown in Figure 1-A, HEI-OC1 cells were treated with various concentrations of α-tocopherol 
(1–20 μM) for 48 h. Alpha-tocopherol at concentrations of more than 20 μM significantly induced 
cytotoxicity as compared with concentrations of less than 10 μM in the HEI-OC1 cells (***p <
0.001). Thus, 10 μM was chosen as the ideal α-tocopherol concentration to demonstrate a protective 
effect against cisplatin-induced ototoxicity. Compared with the negative control, 10 μM α-
tocopherol did not promote cellular growth, showing similar cell viability (99.7 ± 8%, not significant 
as compared to the control group; p > 0.05).
Alpha-tocopherol at a concentration of 10 μM provided significant protection (50.3 ± 2.7% for 
the cisplatin group vs. 69.1 ± 6.4% for the cisplatin-plus-tocopherol group) against the toxic effect 
７of 15 μM cisplatin applied for 48 h (***p < 0.001). Compared with the cisplatin group, treatment 
with 5 μM α-tocopherol also showed significant protective effect against cytotoxicity (***p < 0.001), 
but treatment with 1 μM α-tocopherol did not show any beneficial effect (p > 0.05).
Cisplatin-induced ototoxicity and the protective effect of α-tocopherol were also verified by 
microscopic morphological examination. Cell lines incubated with cisplatin or α-tocopherol were 
stained with Hoechst 33342 and DCFH-DA. In the control group, normal auditory cells were well-
cultured and spindle-shaped (Fig. 2-A). In the group treated with 10 μM α-tocopherol, auditory cells 
had an appearance similar to the cells in the control group (Fig. 2-B). Under treatment with 15 μM
cisplatin, the cell population was decreased, necrotic cell bodies were increased, and ROS were 
increased (Fig. 2-C). In the cisplatin-plus-tocopherol group, α-tocopherol protected HEI-OC1 cells 
against cisplatin-induced cytotoxicity. Compared with the cisplatin group, the cell population was 
increased, and both necrotic bodies and ROS were decreased (Fig. 2-D). Thus, the protective effect 
of α-tocopherol on cisplatin-induced cytotoxicity was seen microscopically in auditory cells, 
reflecting similar results as obtained by the cell viability assay.
3.2. Alpha-tocopherol significantly reduced the cisplatin-induced increase in ROS
To investigate the effects of α-tocopherol on intracellular ROS generation induced by cisplatin, 
auditory cells were treated with 15 μM cisplatin in the presence or absence of 10 μM α-tocopherol
for 48 h. Measurement of ROS was completed by using a FACScan flow cytometer (Fig. 3-A). 
Compared to the control group (100%), the cisplatin group showed significant ROS generation 
(178.8 ± 12%, ***p < 0.001). However, ROS production in the cisplatin-plus-tocopherol group 
(151.5 ± 17%) was significantly lower than that in the cisplatin group (**p < 0.01). There was no 
８significant difference in ROS production between the control and α-tocopherol (85.5 ± 6%, p >
0.05).
3.3. Alpha-tocopherol significantly reduced both cisplatin-induced necrosis and late apoptosis
Flow cytometry analysis showed patterns of cell death such as necrosis or late apoptosis (Fig. 4-
A). In both the control and 10 μM α-tocopherol groups, the percentages of necrosis and late apoptosis 
were similar (3 ± 2.7% and 2.7 ± 1.2% in control, 3.3 ± 2.6% and 2.9 ± 1.7% in α-tocopherol). In 
the 15 μM cisplatin group, a significant increase in density was observed in both necrosis and late 
apoptosis area (14.4 ± 6.7% and 37.7 ± 7.2%, respectively), as compared with the control and 
tocopherol groups (**p < 0.01 and ***p < 0.001). Alpha-tocopherol treatment significantly reduced 
both necrosis and late apoptosis (Fig. 4-B). Necrosis was reduced from 14.4% to 7.1 ± 6% (*p <
0.05), and late apoptosis was reduced from 37.7% to 18.2 ± 6.8% (***p < 0.001). 
3.4. Alpha-tocopherol inhibited the expression of caspase-3 activity
Caspase-3 activity is involved in cisplatin-induced toxicity and related to apoptotic changes in 
cisplatin ototoxicity. The administration of 15 mM cisplatin increased the activity of caspase-3 (7.61 
± 1.31 fold over the normal control) (Fig. 5). Pretreatment of HEI-OC1 cells with α -tocopherol, 
however, significantly reduced caspase-3 activity (6.83 ± 1.28-fold over the normal control) 
compared with cells treated with cisplatin alone (*p < 0.05). 
９3.5. Alpha-tocopherol inhibited the expression of PARP related to cisplatin-induced apoptosis
The cleavages of PARP facilitate cellular disassembly and serve as a marker of cells undergoing 
apoptosis. In the cisplatin-treated group, increased cleavage of PARP was observed (2.42 ± 1.84 fold 
over the normal control) (Fig. 6). The pretreatment of HEI-OC1 cells with 10 μM α-tocopherol
decreased cleaved PARP (1.89 ± 1.38 fold over the normal control) as compared with cells treated 
with cisplatin alone (*p < 0.05). Thus, this result also supports the existence of an anti-apoptotic 
effect of α-tocopherol.
4. Discussion
Many antioxidants have been used to prevent cisplatin-induced ototoxicity, and the protective 
mechanism of antioxidants was thought to be due to inhibition of ROS production, reduction of 
apoptosis, and improvement in cell viability. Glutathione and metformin especially were proven to 
be effective antioxidants in reducing ROS and cellular apoptosis [1, 6, 15]
In this study, we investigated the protective mechanisms of α-tocopherol on cisplatin-induced 
otototoxicity using ROS and sequential apoptotic cascade. Alpha-tocopherol can reduce ROS 
production by 15% and decrease necrosis and late apoptosis by about 50% in cisplatin-induced
cytotoxicity. α-tocopherol significantly decreased caspase-3 activity and reduced the cleaved PARP. 
Caspase-3 is well known for factor that activates endonuclease and lead to cell death, and it is 
responsible for the proteolytic reaction of protein, such as PARP, which is important role of cell 
viability. We also demonstrated that α-tocopherol protects cells from cisplatin-induced ototoxicity, 
although it did not promote cellular growth. Thus, tocopherol showed a 36.2% increase in cell 
viability as compared with cisplatin, which is comparable to an 18.9% increase of outer hair cell 
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viability in an in vivo study of guinea pigs [9]. 
Alpha-tocopherol protects hair cells from oxidative damage by trapping peroxide radicals, 
interrupting and suppressing the lipid peroxidation chain reaction, and directly clearing superoxide 
anion radicals [10]. Antioxidant compounds may also function as free radical scavengers and can 
ensure upstream protection of the cochlea before cellular activation of the apoptotic pathway [13]. 
Because cisplatin induces oxidative stress, it can cause irreversible cell damage and apoptosis [14]
by interacting with nucleophilic sites on the DNA chain [15]. 
An animal study demonstrated the protective effect of tocopherol on hearing damage. Alpha-
tocopherol suppressed cisplatin-induced hearing loss at high frequencies, substantial outer hair cell 
(OHC) losses in the basal and second turns of the cochlea, increases in lipid peroxidation with 
apoptotic changes of the cochlea, increases in creatinine (Cr) and blood urea nitrogen (BUN) levels 
in the serum, and body weight loss [9].
Furthermore, tocopherol does not interfere with the antitumor efficacy of cisplatin while 
protecting from cisplatin-induced systemic and neurologic toxicities [11]. Sarna et al. found 
enhanced tumor growth inhibition in mice with lymphoma when the animals received both vitamin 
E and cisplatin [16]. A diet rich in several antioxidants, including vitamin E, was able to slow the 
growth rate of lung carcinoma in mice receiving cisplatin [17]. Enhanced cisplatin antitumor activity 
against neuroblastoma in mice receiving vitamin E was also reported [18]. The mechanism of the 
enhanced antineoplastic activity of cisplatin in animals receiving vitamin E is unclear, but some 
authors think that it may be due to increased cell membrane permeability to cisplatin [16-18].
１１
Additionally, α-tocopherol has been demonstrated to be effective against damage induced by other 
exogenous factors such as noise and gentamicin-induced oto-vestibulotoxicity in guinea pigs [19, 
20].
Although our experiment was conducted with an HEI-OC1 cell line designed to evaluate drug-
induced ototoxicity, clinical availability of tocopherol in patients treated with cisplatin also remains 
uncertain. Further studies will be focused on animal experiments to confirm the underlying 
protective mechanism and to establish the appropriate dose of α-tocopherol applicable in the clinical 
setting.
5. Conclusion
Alpha-tocopherol significantly reduced the cisplatin-induced increase of ROS and decreased 
cellular necrosis and late apoptosis, thereby inhibiting cisplatin-induced cytotoxicity in HEI-OC1 
cells. Our study suggests that α-tocopherol might be useful as a preventive supplement for patients 
receiving cisplatin who have concerns about potential ototoxicity.
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Figure 1. Effect of α-tocopherol in the auditory cell line culture. (A) HEI-OC1 cells were treated 
with various concentration of α-tocopherol (1–20 μM) for 48 h. Results show that α-tocopherol at 
concentrations of more than 20 μM significantly induced cytotoxicity as compared with 
concentrations of less than 10 μM (***p < 0.001). Thus, 10 μM was chosen as the ideal α-tocopherol
concentration to demonstrate a protective effect against cisplatin-induced ototoxicity. (B) Alpha-
tocopherol provided significant protection (50.3% ± 2.7% for the cisplatin group vs. 69.1% ± 6.4% 
for the cisplatin-plus-tocopherol group) against the toxic effect of 15 μM cisplatin applied for 48 h 
(***p < 0.001, as compared with the cisplatin group, results from 7 separate experiments in 
triplicate).
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Figure 2. Representative microscopic appearance of HEI-OC1 cells stained with Hoechst 33342 (left) 
and 2′,7′-dichlorofluorescein diacetate (DCFH-DA, right): Protective effect of α-tocopherol on 
cisplatin-induced cytotoxicity in the auditory cell culture. (A) Control. (B) 10 μM α-tocopherol, 
which has a similar appearance to the control group. (C) 15 μM cisplatin. This figure shows a 
decreased cell population and necrotic cell bodies, and increased reactive oxygen species (ROS). (D) 
Cisplatin-plus-tocopherol group. Alpha-tocopherol protected against cisplatin-induced cytotoxicity. 
Compared with the cisplatin group, the cell size was within the normal range. Necrotic bodies and 
ROS were decreased. Left picture: Hoechst stains, Right picture: DCFDA fluorescent confocal 
microscope (×200).
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Figure 3. Measurement of intracellular reactive oxygen species (ROS) production. (A) 
Representative figure measured ROS by using a FACScan flow cytometer: Protective effect of α-
tocopherol on cisplatin-induced cytotoxicity in the auditory cell culture. ROS production in the 
cisplatin-plus-tocopherol group (red) was significantly lower than that in the cisplatin group (blue). 
Control (black) and α-tocopherol treated group (gray) have similar ROS productions, which are 
significantly lower than the cisplatin group or the cisplatin-plus-tocopherol group. (B) Summary of 
the anti-ROS effect of α-tocopherol on cisplatin-induced cytotoxicity in auditory cells. In the 
cisplatin group, ROS was increased by 178.8% as compared with control, but α-tocopherol treatment 
significantly reduced ROS production to 151.5% (**p < 0.01, as compared with cisplatin-treated 
group, results from 5 separate experiments in triplicate).
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Figure 4. Apoptosis study of α-tocopherol. (A) Representative data of flow cytometry analysis 
showed cellular apoptosis patterns such as necrosis (left-upper panel) or late apoptosis (right-upper 
panel). In the 15 μM cisplatin group, increased density was observed in late apoptosis area. However, 
tocopherol treatment reduced the density in both upper panels. (B) Application of 15 μM cisplatin 
induced a significant increase of both necrosis and late apoptosis, as compared with control and 
tocopherol groups (**p < 0.01). Alpha-tocopherol treatment significantly reduced both necrosis and 
late apoptosis. Necrosis was reduced from 14.4% to 7.1% (*p < 0.05), and late apoptosis was 
reduced from 37.7% to 18.2% (***p < 0.001). Results from 7 separate experiments.
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Figure 5. Measurement of caspase-3 activity. Data shows that pretreatment α-tocopherol, compared 
with cisplatin alone, inhibited the expression of caspase-3 (7.61 ± 1.31 fold over the normal control 
for the cisplatin group vs. 6.83 ± 1.28 fold over the normal control for the cisplatin-plus-tocopherol 
group). (*p < 0.05, compared with the cisplatin-treated group.)
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Figure 6. Immunoblotting of PARP. In the cisplatin treated group, increased cleavage of PARP was 
observed (2.42 ± 1.84 fold over the normal control). The pretreatment of HEI-OC1 cells with 10μM 
tocopherol significantly decreased cleaved PARP (1.89 ± 1.38 fold over the normal control) as 
compared with cells treated with cisplatin alone (*p < 0.05) (A, B).
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Abstract
The Effects of the Antioxidant α-Tocopherol on Cisplatin-
Induced Ototoxicity in HEI-OC1 Auditory Cells
Objectives: Alpha-tocopherol is a class of methylated phenols, known as fat-soluble antioxidants, 
and is a different form of vitamin E, which reduces free radicals and acts as an antioxidant. We 
hypothesized that the antioxidative effect of α-tocopherol could protect against cisplastin-induced 
cytotoxicity, and thus evaluated its effects on cisplatin-induced ototoxicity in HEI-OC1 auditory 
cells. Methods: HEI-OC1 cells were pretreated with α-tocopherol at a concentration of 10 μM for 
24 h, and then exposed to 15 μM cisplatin for 48 h. The cellular viability was measured by using the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The intracellular 
reactive oxygen species (ROS) level was measured by using a fluorescent dye, 2′,7′-
dichlorofluorescein diacetate (DCFH-DA). Both Annexin V-FITC and propidium iodide (PI) 
staining were performed to analyze the pattern of apoptosis. The enzymatic activity of caspase-3 
was assayed with caspase3/CPP32 fluorometric assay kit. Also, it was assessed by immunoblotting 
technique of poly-ADP-ribose polymerase (PARP). Results: Pretreatment with 10 μM α-tocopherol 
protected HEI-OC1 auditory cells against cisplatin-induced cytotoxicity. Alpha-tocopherol 
significantly reduced the cisplatin-induced increase in ROS. Alpha-tocopherol treatment induced a 
15% reduction of ROS and 50% decrease in necrosis and late apoptosis as compared to cisplatin 
treatment. Alpha-tocopherol also decreased the activation of caspase-3 and reduced levels of PARP. 
Conclusion: This study was investigated the protective effects of α-tocopherol on cisplatin-induced 
ototoxicity in an auditory cell line. Tocopherol significantly reduced a cisplatin-induced increase in 
２２
ROS, thereby inhibiting cisplatin-induced cytotoxicity. 
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